Advertisement
Screener

Citius Oncology, Inc. (CTOR) ROA

CITIUS ONCOLOGY, INC. ROA

Return on assets (ROA) is the profit a company earns for every dollar of assets it uses, shown as a percentage. It is net income divided by total assets, and the table shows both amounts. Because assets are funded by lenders as well as shareholders, ROA is not inflated by borrowing the way ROE can be, and it is naturally lower for businesses that need many factories, stores or other assets. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • CITIUS ONCOLOGY, INC. roa for the quarter ending 2026-06-30 was -41.09%, a change of -12.11% year-over-year.
  • CITIUS ONCOLOGY, INC. roa for the quarter ending 2026-03-31 was -42.22%, a change of -13.80% year-over-year.
  • CITIUS ONCOLOGY, INC. roa for the quarter ending 2025-12-31 was -21.49%, a change of 4.02% year-over-year.
  • CITIUS ONCOLOGY, INC. roa for the quarter ending 2025-09-30 was -24.53%, a change of 0.54% year-over-year.
  • CITIUS ONCOLOGY, INC. roa for fiscal 2025 was -24.53%, a change of 0.54% from fiscal 2024.
  • CITIUS ONCOLOGY, INC. roa for fiscal 2024 was -25.07%.
  • CITIUS ONCOLOGY, INC. roa for fiscal 2023 was 3.33%.
  • CITIUS ONCOLOGY, INC. roa for fiscal 2023 was -26.60%.
Available history
2022-12-31 to 2026-06-30
Data captured

Historical ROA

DateROANet income 12 monthNet income 3 monthTotal assets
2026-06-30-41.09%-$46.06M-$8.92M$112.09M
2026-03-31-42.22%-$42.51M-$26.61M$100.7M
2025-12-31-21.49%-$23.64M-$5.53M$109.97M
2025-09-30-24.53%-$24.76M-$5.00M$100.94M
2025-06-30-28.98%-$26.58M-$5.37M$91.71M
2025-03-31-28.41%-$25.98M-$7.74M$91.44M
2024-12-31-25.51%-$23.08M-$6.66M$90.48M
2024-09-30-25.07%-$21.15M-$6.81M$84.37M
2024-06-30-28.82%-$14.18M-$4.77M$49.19M
2024-03-31-18.05%-$8.79M-$4.84M$48.68M
2023-12-31-4.60%-$3.34M-$4.73M$72.62M

Annual ROA

DateROANet income 12 monthTotal assets
2025-09-30-24.53%-$24.76M$100.94M
2024-09-30-25.07%-$21.15M$84.37M
2023-12-313.33%$2.42M$72.62M
2023-09-30-26.60%-$12.7M$47.73M
2022-12-310.56%$380,811.00$68.19M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Anixa Biosciences Inc (ANIX)United States$0.096B
Milestone Pharmaceuticals Inc. (MIST)$0.098B-2.00
ProMIS Neurosciences Inc. (PMN)$0.102B
Acrivon Therapeutics, Inc. (ACRV)United States$0.091B-1.03
Rallybio Corp (RLYB)United States$0.089B
Polaryx Therapeutics, Inc. (PLYX)United States$0.106B
ONCOLYTICS BIOTECH INC (ONCY)$0.086B
Biomea Fusion, Inc. (BMEA)United States$0.107B-3.30
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)United States$0.086B
Equillium, Inc. (EQ)United States$0.109B-11.27